Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 400,283 | 183,049 | 108,345 | 157,018 | 151,850 |
| Marketable Securities | 519,746 | 518,609 | 590,427 | 368,096 | 316,901 |
| Receivables | 20 | 1 | 15 | 18 | 6,703 |
| TOTAL | $932,214 | $713,179 | $709,353 | $532,632 | $482,182 |
| Non-Current Assets | |||||
| PPE Net | 8,235 | 7,122 | 6,909 | 6,164 | 6,192 |
| Investments And Advances | 280,128 | 251,071 | 242,636 | 107,492 | 42,394 |
| Other Non-Current Assets | 19,296 | 2,291 | 2,629 | 3,028 | 2,174 |
| TOTAL | $307,659 | $260,484 | $252,174 | $116,684 | $50,760 |
| Total Assets | $1,239,873 | $973,663 | $961,527 | $649,316 | $532,942 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,567 | 15,886 | 6,290 | 6,598 | 5,169 |
| Accrued Expenses | 28,092 | 24,250 | 17,519 | 18,756 | 16,188 |
| Other current liabilities | N/A | N/A | N/A | N/A | 1,439 |
| TOTAL | $40,659 | $40,742 | $24,960 | $27,101 | $24,893 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 18,796 | 1,263 | 1,256 | 1,125 | 0 |
| TOTAL | $18,796 | $1,263 | $1,256 | $1,125 | $N/A |
| Total Liabilities | $59,455 | $42,005 | $26,216 | $28,226 | $24,893 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,432 | 84,482 | 75,687 | 74,560 | 64,459 |
| Common Shares | 9 | 8 | 7 | 7 | 6 |
| Retained earnings | -492,529 | -440,708 | -387,936 | -348,364 | -314,409 |
| Other shareholders' equity | 3,836 | -1,416 | -923 | 562 | -750 |
| TOTAL | $1,180,418 | $931,658 | $935,311 | $621,090 | $508,049 |
| Total Liabilities And Equity | $1,239,873 | $973,663 | $961,527 | $649,316 | $532,942 |